ATE378091T1 - Verwendung von optischen aufhellern - Google Patents

Verwendung von optischen aufhellern

Info

Publication number
ATE378091T1
ATE378091T1 AT00987366T AT00987366T ATE378091T1 AT E378091 T1 ATE378091 T1 AT E378091T1 AT 00987366 T AT00987366 T AT 00987366T AT 00987366 T AT00987366 T AT 00987366T AT E378091 T1 ATE378091 T1 AT E378091T1
Authority
AT
Austria
Prior art keywords
optical brighteners
human skin
radiation
carrier material
whitening agent
Prior art date
Application number
AT00987366T
Other languages
German (de)
English (en)
Inventor
Dieter Reinehr
Helmut Luther
Georges Metzger
Original Assignee
Ciba Sc Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Sc Holding Ag filed Critical Ciba Sc Holding Ag
Application granted granted Critical
Publication of ATE378091T1 publication Critical patent/ATE378091T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Liquid Crystal Substances (AREA)
AT00987366T 1999-12-13 2000-12-07 Verwendung von optischen aufhellern ATE378091T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99811154 1999-12-13

Publications (1)

Publication Number Publication Date
ATE378091T1 true ATE378091T1 (de) 2007-11-15

Family

ID=8243184

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00987366T ATE378091T1 (de) 1999-12-13 2000-12-07 Verwendung von optischen aufhellern

Country Status (8)

Country Link
US (1) US6818205B2 (enExample)
EP (1) EP1237536B1 (enExample)
JP (1) JP2003516954A (enExample)
AT (1) ATE378091T1 (enExample)
AU (1) AU2363501A (enExample)
DE (1) DE60037135T2 (enExample)
ES (1) ES2295075T3 (enExample)
WO (1) WO2001043714A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2830189B1 (fr) 2001-09-28 2004-10-01 Oreal Composition de teinture a effet eclaircissant pour fibres keratiniques humaines
US7261744B2 (en) 2002-12-24 2007-08-28 L'oreal S.A. Method for dyeing or coloring human keratin materials with lightening effect using a composition comprising at least one fluorescent compound and at least one optical brightener
FR2848822B1 (fr) * 2002-12-24 2006-01-13 Oreal Composition cosmetique de type fond de teint destinee au maquillage des peaux foncees
FR2853231B1 (fr) * 2003-04-01 2008-10-03 Oreal Composition de coloration pour matieres keratiniques humaines comprenant un colorant fluorescent et un agent sequestrant particulier, procede et utilisation
US7147673B2 (en) 2003-04-01 2006-12-12 L'oreal S.A. Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one insoluble polyorganosiloxane conditioning polymer, process therefor and use thereof
FR2853240A1 (fr) * 2003-04-01 2004-10-08 Oreal Composition de coloration pour matieres keratiniques humaines comprenant un colorant fluorescent et un polymere associatif, procede et utilisation
US7208018B2 (en) 2003-04-01 2007-04-24 L'oreal Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one associative polymer, process therefor and use thereof
US7204860B2 (en) 2003-04-01 2007-04-17 L'oreal Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one polyol, process therefor and use thereof
US7186278B2 (en) 2003-04-01 2007-03-06 L'oreal S.A. Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one compound comprising an acid functional group and processes therefor
US7736631B2 (en) 2003-04-01 2010-06-15 L'oreal S.A. Cosmetic dye composition with a lightening effect for human keratin materials, comprising at least one fluorescent dye and at least one aminosilicone, and process of dyeing
US7192454B2 (en) 2003-04-01 2007-03-20 L'oreal S.A. Composition for dyeing human keratin materials, comprising a fluorescent dye and a particular sequestering agent, process therefor and use thereof
US7195651B2 (en) 2003-04-01 2007-03-27 L'oreal S.A. Cosmetic composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one cationic polymer, and a dyeing process therefor
US7195650B2 (en) 2003-04-01 2007-03-27 L'oreal S.A. Process for dyeing, with a lightening effect, human keratin fibers that have been permanently reshaped, using at least one composition comprising at least one fluorescent dye
US7250064B2 (en) 2003-04-01 2007-07-31 L'oreal S.A. Dye composition comprising at least one fluorescent dye and a non-associative thickening polymer for human keratin materials, process therefor, and method thereof
FR2853234B1 (fr) * 2003-04-01 2007-10-12 Oreal Composition de coloration comprenant un colorant fluorescent et un polymere epaississant non associatif pour matieres keratiniques humaines, procede et utilisation
US7150764B2 (en) 2003-04-01 2006-12-19 L'oreal S.A. Composition for dyeing a human keratin material, comprising at least one fluorescent dye and at least one insoluble conditioning agent, process thereof, use thereof, and devices thereof
US7303589B2 (en) 2003-04-01 2007-12-04 L'oreal S.A. Process for dyeing human keratin fibers, having a lightening effect, comprising at least one fluorescent compound and compositions of the same
US7198650B2 (en) 2003-04-01 2007-04-03 L'oreal S.A. Method of dyeing human keratin materials with a lightening effect with compositions comprising at least one fluorescent dye and at least one amphoteric or nonionic surfactant, composition thereof, process thereof, and device therefor
KR20060033005A (ko) * 2003-07-16 2006-04-18 시바 스폐셜티 케미칼스 홀딩 인코포레이티드 피부를 처리하기 위한 할로겐화된 히드록시디페닐 에테르화합물의 용도
FR2873021A1 (fr) * 2004-07-16 2006-01-20 Oreal Composition cosmetique a particules photoluminescentes.
WO2006011014A1 (en) * 2004-07-16 2006-02-02 L'oreal Cosmetic composition containing photoluminescent particles
US20060024340A1 (en) * 2004-07-30 2006-02-02 Elder Stewart T Encapsulated fluorescent whitening compositions for improved surface appearance
US20070264293A1 (en) * 2004-09-10 2007-11-15 Elder Stewart T Encapsulated Fluorescent Whitening Compositions and Their Use in Personal Care Applications
FR2956028B1 (fr) 2010-02-08 2012-03-02 Oreal Composition cosmetique incluant au moins un compose fluorophore.
EP2776005B1 (en) 2011-11-07 2017-01-25 Colgate-Palmolive Company Tooth film formulations
US9545371B2 (en) * 2015-03-20 2017-01-17 Elc Management Llc Method of making an optically-activated system
US10030022B2 (en) 2015-03-20 2018-07-24 Elc Management Llc Method of stabilizing riboflavin
US9962565B2 (en) 2015-03-20 2018-05-08 Elc Management Llc Optically-activated system for reducing the appearance of skin imperfections
US20160361239A1 (en) 2015-06-12 2016-12-15 L'oreal Cosmetic composition comprising an ordered macroporous material
US10729641B2 (en) 2015-06-12 2020-08-04 Regents Of The University Of Minnesota Ordered macroporous materials

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06312920A (ja) * 1993-05-06 1994-11-08 Kao Corp 美白剤及びこれを含有する皮膚化粧料
GB9509291D0 (en) * 1995-05-06 1995-06-28 Ciba Geigy Ag Formulations
AU4486397A (en) * 1997-09-17 1999-04-05 Procter & Gamble Company, The Hair care compositions comprising optical brighteners and polymeric suspending agents
US6313181B1 (en) * 1999-05-26 2001-11-06 Color Access, Inc. Cosmetic compositions containing optical brighteners

Also Published As

Publication number Publication date
US6818205B2 (en) 2004-11-16
WO2001043714A1 (en) 2001-06-21
AU2363501A (en) 2001-06-25
DE60037135T2 (de) 2008-09-11
DE60037135D1 (de) 2007-12-27
US20030103924A1 (en) 2003-06-05
JP2003516954A (ja) 2003-05-20
ES2295075T3 (es) 2008-04-16
EP1237536B1 (en) 2007-11-14
EP1237536A1 (en) 2002-09-11

Similar Documents

Publication Publication Date Title
ATE378091T1 (de) Verwendung von optischen aufhellern
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
BR9808491A (pt) Compostos calcilìticos
BR0015110A (pt) Métodos de tratamento de doenças de proliferação celular, de tratamento de um distúrbio associado com a atividade da cinesina ksp, de inibição da cinesina ksp, de triagem de moduladores da cinesina kps e de triagem de compostos que se ligam na cinesina ksp, e, compostos
SE0301298L (sv) Vitgjord fluffmassa
BR9713109A (pt) Derivados simétricos de triazina
DE59902314D1 (de) Oligomerisiertes Organopolysiloxan-Cokondensat, dessen Herstellung und dessen Verwendung zur Behandlung von Oberflächen
HN1996000017A (es) Isotiazolonas
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
DE69534360D1 (de) Zentrale Quelle von mehreren Wellenlängen
DE69623472D1 (de) Derivate von dolastatin, dreen herstellung un verwendung
DE69224095D1 (de) Wiedergewinnbarer Strahlungsquellenträger
ATE227127T1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
DE69510575D1 (de) Verwendung von silikontrennschichtmittel
DE69923044D1 (de) Gewebebehandlungsmittel, Gewebe, Textildruckverfahren sowie Druck
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
ATE229034T1 (de) 3-mercaptoacetylamino-1,5-substituierte-2-oxo- azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
TW332827B (en) UV absorber
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
EP1185276A4 (en) ISOPHOSPHORAMIDE MUSTARD GAS ANALOGS AND THEIR USE
DE69827509D1 (de) Überwachung und/oder detektion von alpha-strahlungsquellen
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
DE50011084D1 (de) Verwendung von azolen zur prävention von strahlen-induziertem hautkrebs
ATE228517T1 (de) Piperidinylmethyloxazolidin-2-on derivate, deren herstellung und deren verwendung als zns wirksame verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties